Complexing cis-diaminedichloroplatinum-loaded magnetic nano-medicine for treating nasopharyngeal carcinoma in vitro

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 13, Issue 29, 2009, Pages 5637-5640

  Li, Zhong Han ^a   Xie, Min Qiang ^b   Chen, Shuai Jun ^b   Wang, Lei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL KILLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 69749110786     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-8225.2009.29.007     Document Type: Article

References (14)

1. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol. 2002;25(3):219-223. (Pubitemid 34602538)
2. Li WG, Chen WL, Ai H, et al. Cellular Toxic Effect of Low Dose Cisplatin Combined with Interstitial Injection of 32P Glass Microspheres on Mouse Solid Tumor S180. Zhongshan Daxue Xuebao: Yixue Kexueban. 2005;26(1):65-68.
3. Tian J, Pang X, Yu K, et al. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin. Pharmazie. 2008;63(8):593-597.
4. Li XS, Li WQ, Wang WB. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment. Cancer Biother Radiopharm. 2007;22(6):772-778.
5. Xie MQ, Chen SJ, Xu XQ, et al. Preparation and characteristic comparison of two kinds of cis-diaminedichloroplatinum-loaded magnetic nanoparticles. Kexue Tongbao. 2005;50(19):2079-2084.
6. Avichezer D, Schechter B, Arnon R, et al. Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates: effect on human ovarian carcinoma. Reactive and Functional Polymers. 1998;36(1):59-69. (Pubitemid 128391560)
7. Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008;127(1):41-49.
8. Tang T, Zheng JW, Li H, et al. A comparative study of targeting drug magnetic nanoparticles and other chemotherapy drugs on human cholangiocarcinoma xenografts. Zhongguo Putong Waike Zazhi. 2007;16(2):121-124.
9. Zhang HZ, Xie MQ, Kang Z, et al. Targeted distribution of cis-platin magnetic nanoparticles in mice. Diyi Junyi Daxue Xuebao. 2008;28(10):1756-1759.
10. Chen SJ, Xie MQ, Wang L, et al. Safety Assessment of Modified Cisplatinum Magnetic Nanomedicine. Zhongguo Yaofang. 2008;19(25):1941-1943.
11. Fu LW, Liang YJ, Pan QC. Study of Anticancer Effect of Hydroxycampothecin-based Combination against Experimental Nasopharyngeal Carcinoma. Aizheng. 2001;20(4):363-367.
12. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials. 2005;26(13):1565-1573. (Pubitemid 39441388)
13. Tao KX, Xia ZF, Wang GB. Preparation and characteristics of dextran-coated Iron oxide nanoparticle. Huazhong Keji Daxue Xuebao: Yixueban. 2006;35(5):653-655.
14. Wilhelm C, Billotey C, Roger J, et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials. 2003;24(6):1001-1011. (Pubitemid 36024170)